AI impacts care in so many ways now that it often goes unnoticed by clinicians. 

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care. 

The OpusWave Dual Sensor Imaging System captures both IVUS and OFDI, providing users with two complementary views of the coronaries at the same time.

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Current research suggests this technology is just getting started when it comes to transforming patient care.

MRI-detected signs of cardiac remodeling may tell clinicians a thing or two about a patient's odds of developing certain cancers. Changes in heart muscle mass, for example, were linked to an increased risk of breast cancer. 

The new guideline emphasizes the importance of 3D multiplanar reconstruction for M-TEER to increase precision.